Currently available medications could be enough to end the HIV epidemic in the United States, provided people can access and ...
Nursing home patients with HIV tend to be younger. They also typically have more comorbidities than the average patient, and ...
ScienceAlert on MSN
HIV's Cunning Strategy For Hiding in Our Body Finally Revealed
According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...
We finally have the technology, infrastructure, and the political will to end the US HIV epidemic, write the Brown University ...
A new analysis finds that generic lenacapavir, a twice-yearly HIV preventive treatment, could be mass produced for just $25 ...
Early initiation of antiretroviral therapy does not provide significant cardiovascular benefits compared with delayed ...
The biopharma will aim to bolster its pipeline, with plans to present updated results for novel long-acting combination ...
The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...
Among patients with late diagnosed HIV infection, the choice of a two- or three-drug regimen is not associated with 48 week ...
South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...
"Accredited South African pharmacists can now legally prescribe essential HIV medications, a landmark Supreme Court ruling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback